Ledger.Open graph →
SEC Form D · Amendment · filed July 11, 2019

Kiniksa Pharmaceuticals, Ltd

Offering
$7.5M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HAMILTON, Bermuda
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Barry D. Quart · HAMILTON, BermudaDirectorEric Kanagy · Brooklyn, NYDirectorChristopher P. Mundy · NEW YORK, NYDirectorAlex Brickner · Brooklyn, NYDirectorDominic Napolitano · Darien, CTDirectorAndrea Fellows · NEW YORK, NYExec · DirectorUpper90 Capital Management LP · New York, NYDirectorKristen P. Binck · NEW YORK, NYExecSam P. Johnson · NEW YORK, NYDirectorRick K. Briggs · Old Bridge, NJExec · DirectorJames F. Williams · Old Bridge, NJExecSteven L. Shea · Old Bridge, NJDirectorGary P. Scharmett · Old Bridge, NJDirectorStephen K. Necessary · Old Bridge, NJDirectorCharles E. Dietz · Old Bridge, NJDirectorAnthony R. Bruno · Old Bridge, NJDirectorEric R. Skolnik · Old Bridge, NJDirectorEdward R. Grauch · Old Bridge, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗